Virtu Financial LLC Kazia Therapeutics LTD Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.2 - $0.46 $7,855 - $18,067	39,277 New	39,277 $9,000
Q4 2023 Feb 26, 2024	SELL	$0.39 - $0.99 $74 - $188	-190 Reduced 1.63%	11,449 $5,000
Q3 2023 Nov 14, 2023	BUY	$0.84 - $1.17 $9,776 - $13,617	11,639 New	11,639 $12,000
Q3 2022 Nov 07, 2022	BUY	$1.1 - $4.19 $13,535 - $51,557	12,305 New	12,305 $14,000

2.13M

93.2K

Ticker KZIA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,111,300
Market Cap $87.5M
Description
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.